Global Contrast Media Injectors Market Overview
Contrast Media Injectors Market was valued at US$ 1.5 Billion in 2024 and is projected to grow at a CAGR of 7.50% to reach US$ 3.1 Billion by 2034.
Contrast media injectors are the radio-opaque injectors which allow injecting media into the body to enhance the visibility of tissues for a medical imaging procedure. Contrast media injectors which are used for injecting computed tomography iodine-based contrast agents are known as CT injectors. Medical devices employed for injecting radio-opaque contrast media into the body to reinforce the visibility of tissues for a medical imaging procedure are referred to as contrast injectors. Over the years, with ever-increasing technological sophistication, these contrast injectors have evolved from manual injectors having manifolds with stop-cocks to automated versions, providing added accuracy and advantages. These automated versions are referred to as auto injectors. Auto injectors are capable of controlling the quantity of contrast media injected, utilization rate, and also are ready to increase dosage to stay pace with fast medical imaging scanners also as alert the physician of potential hazards, like air embolisms or extravasations.
Global Contrast Media Injectors Market Dynamics
Increasing prevalence of several chronic diseases
Increasing prevalence of several chronic diseases such as cancer as well as cardiac, neurological, and orthopedic diseases amongst individuals are factors fuelling growth of the global contrast media injectors market. In addition, rising demand for minimally invasive surgeries is major factor driving growth target market.
Growing number of regulatory approvals
Furthermore, growing number of regulatory approvals for contrast media injectors, coupled with rapidly growing technological advancements in contrast media injectors are some other factors boosting growth of the global contrast media injectors market.
However, adverse effects associated with contrast agents including iodinated contrast, barium, gadolinium, and micro bubble agents decreases their adoption by healthcare professionals are limiting the growth of target market.
Global Contrast Media Injectors Market Segmentation
The contrast media injectors market has been segmented on the basis of type, application, and region.
The type segment includes MR injectors, CT injectors, and vascular injectors. On the basis of application the global contrast media injectors market has been segmented as neurology, cardiology, and oncology.
Regional Insights:
For detailed understanding of market dynamics, On the basis of region the global contrast media injectors market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the major share in terms of revenue as compared to the other regions. This can be attributed to advanced facilities for medical imaging technologies are available in the region of the countries. Asia Pacific is predicted to grow at the very best CAGR during the forecast period, primarily thanks to factors like the rising R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investment within the Indian radiology market, and increasing focus of market players & increasing government support to strengthen healthcare service delivery in other countries are driving the expansion of this regional segment
Attribute |
Details |
Base year for estimation |
2023 |
Forecast period |
2024 – 2034 |
Market representation |
Revenue in USD Million & CAGR from 2024 – 2034 |
Market Segmentation |
By Type: MR Injectors, CT Injectors, and Vascular Injectors By Application: Neurology, Cardiology, and Oncology |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Contrast Media Injectors Market, By Type:
- MR Injectors
- Vascular Injectors
- CT Injectors
Contrast Media Injectors Market, By Application:
- Neurology
- Oncology
- Cardiology
Contrast Media Injectors Market, By Region:
- North America
- Africa
- Africa Contrast Media Injectors Market, By Type
- Africa Contrast Media Injectors Market, By Application
- Africa Contrast Media Injectors Market, By Country
- North Africa
- Central Africa
- South Africa
- Middle East
- Middle East Contrast Media Injectors Market, By Type
- Middle East Contrast Media Injectors Market, By Application
- Middle East Contrast Media Injectors Market, By Country
- GCC
- Israel
- Rest of Middle East
- Latin America
- Latin America Contrast Media Injectors Market, By Type
- Latin America Contrast Media Injectors Market, By Application
- Latin America Contrast Media Injectors Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia-Pacific
- Asia-Pacific Contrast Media Injectors Market, By Type
- Asia-Pacific Contrast Media Injectors Market, By Application
- Asia-Pacific Contrast Media Injectors Market, By Country
- China
- India
- Australia
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Contrast Media Injectors Market, By Type
- Europe Contrast Media Injectors Market, By Application
- Europe Contrast Media Injectors Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Contrast Media Injectors Market, By Type
- North America Contrast Media Injectors Market, By Application
- North America Contrast Media Injectors Market, By Country
- U.S.
- Canada
- Africa
Global Contrast Media Injectors Market Key Players
Some of the prominent players operating in the Key players operating in the global contrast media injectors market includes Bracco Imaging S.p.A., Guerbet Group LLC., MEDTRON AG., Bayer HealthCare LLC., ulrich GmbH & Co. KG., GE Corp., VIVID IMAGING Pvt. Ltd., Sino Medical Sciences Technology Inc., Angio Dynamics Inc., Apollo RT Co. Ltd., and Nemoto Kyorindo Co. Ltd.
Global Contrast Media Injectors Market Company Profile
- Bracco Imaging S.p.A.
- Nemoto Kyorindo Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Apollo RT Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Angio Dynamics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Sino Medical Sciences Technology Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- VIVID IMAGING Pvt. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- GE Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- ulrich GmbH & Co. KG.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Bayer HealthCare LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- MEDTRON AG.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Guerbet Group LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Nemoto Kyorindo Co. Ltd.
Global Contrast Media Injectors Market Highlights
FAQs
The global contrast media injectors market has been segmented on the basis of type, application, and region.
Increasing prevalence of several chronic diseases such as cancer as well as cardiac, neurological, and orthopedic diseases amongst individuals are factors fuelling growth of the global contrast media injectors market.
North America is expected to account for the major share in terms of revenue as compared to the other regions.
Some of the prominent players operating in the Key players operating in the global contrast media injectors market includes Bracco Imaging S.p.A., Guerbet Group LLC., MEDTRON AG., Bayer HealthCare LLC., ulrich GmbH & Co. KG., GE Corp., VIVID IMAGING Pvt. Ltd., Sino Medical Sciences Technology Inc., Angio Dynamics Inc., Apollo RT Co. Ltd., and Nemoto Kyorindo Co. Ltd.